Citadel Securities, Others Beat Biotech Spoofing Suit, For Now <https://www.law360.com/health/articles/1803164?nl_pk=6422bbc2-a823-4be5-9a9f-132770eb1771&utm_source=newsletter&utm_medium=email&utm_campaign=health&utm_content=2024-02-16&read_main=1&nlsidx=0&nlaidx=15> By Katryna Perera A New York federal judge has adopted in full a magistrate judge's recommendation to toss a suit accusing several broker-dealers, including Citadel Securities LLC and Virtu Americas LLC, of carrying out a spoofing scheme that repeatedly drove a biotechnology company's share price down, saying he agrees with the report's finding that the suit fails to show that the alleged scheme caused lower stock prices in every instance. 2 documents attached | Read full article » <https://www.law360.com/health/articles/1803164?nl_pk=6422bbc2-a823-4be5-9a9f-132770eb1771&utm_source=newsletter&utm_medium=email&utm_campaign=health&utm_content=2024-02-16&read_more=1&nlsidx=0&nlaidx=15> | Save to favorites » <https://www.law360.com/health/articles/1803164?nl_pk=6422bbc2-a823-4be5-9a9f-132770eb1771&utm_source=newsletter&utm_medium=email&utm_campaign=health&utm_content=2024-02-16&read_later=1&nlsidx=0&nlaidx=15>